Low Osmolar Contrast Material, 100-199 Mg/ml Iodine Concentration, Per Ml in Georgia
Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.
Top Providers in Georgia
| Provider | Medicare | Services |
|---|---|---|
| Diaz, Ruben MD | $1.15 | 9.2K |
| Kingloff, Daniel MD | $0.96 | 4.8K |
| Day, John M.D. | $1.05 | 4.0K |
| Swayze, Orrin Scott M.D. | $0.90 | 2.9K |
| Ko, Song-Chu M.D. | $0.64 | 2.5K |
| Miller, Wesley DO | $1.16 | 2.4K |
| Ponnusamy, Karthikeyan M.D. | $1.07 | 2.4K |
| Terrell, William M.D. | $0.99 | 1.0K |
| Yoon, Sook Kyung MD | $1.11 | 306 |
| Rowe, Richard MD | $0.99 | 119 |
| Agrawal, Subodh MD | $1.10 | 116 |
| Wallace, Katherine NP-C | $0.97 | 82 |
Georgia Pricing in Context
In Georgia, CPT code Q9965 (Low Osmolar Contrast Material, 100-199 Mg/ml Iodine Concentration, Per Ml) carries an average Medicare payment of $1.02 — 5% above the national benchmark of $0.97. 49 providers across the state submitted claims for this procedure in 2023, performing 34.0K total services. Individual payments in GA ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.
The average billed charge in Georgia is $2.50, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because Georgia sits above the national Medicare average, commercial rates in the state may also run higher than the US median.
Using RAND 2024 commercial-to-Medicare ratios for Temporary Codes procedures, the estimated commercial insurance price in Georgia lands near $2.94, with self-pay cash prices typically around $1.67. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.
Frequently Asked Questions
How much does Low Osmolar Contrast Material, 100-199 Mg/ml Iodine Concentration, Per Ml cost in Georgia?
The average Medicare payment for Low Osmolar Contrast Material, 100-199 Mg/ml Iodine Concentration, Per Ml in Georgia is $1.02, which is 5% above the national average of $0.97. Providers in GA typically bill $2.50 for this procedure.
What does Low Osmolar Contrast Material, 100-199 Mg/ml Iodine Concentration, Per Ml cost with insurance in Georgia?
With commercial insurance in Georgia, Low Osmolar Contrast Material, 100-199 Mg/ml Iodine Concentration, Per Ml costs an estimated $2.94. Without insurance, the estimated cash price is $1.67. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.
How many providers perform Low Osmolar Contrast Material, 100-199 Mg/ml Iodine Concentration, Per Ml in Georgia?
49 providers in Georgia billed Medicare for Low Osmolar Contrast Material, 100-199 Mg/ml Iodine Concentration, Per Ml in 2023, performing 34.0K total services. Medicare payments ranged from N/A to N/A depending on the provider.
Is Low Osmolar Contrast Material, 100-199 Mg/ml Iodine Concentration, Per Ml cheaper in Georgia than the national average?
No — Low Osmolar Contrast Material, 100-199 Mg/ml Iodine Concentration, Per Ml costs 5% above the national average in Georgia. The state average Medicare payment is $1.02 compared to $0.97 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.
Related Guides
Related Data Sources
Data from CMS Medicare Physician & Other Practitioners (2023).
Read our methodology — how this data is sourced, computed, and verified.